Malignant mesothelioma (MM) is an aggressive and lethal cancer, mostly related to
inhalation of asbestos and erionite fibers. MM is associated with poor prognosis, because of …

Malignant pleural mesothelioma (MPM) is an asbestos-related neoplasm, which can be
treated successfully only if correctly diagnosed and treated in early stages. The asbestos …

Purpose: Malignant mesothelioma is a highly aggressive tumor and is often diagnosed too
late for a curative treatment. We compared diagnostic and prognostic values of mesothelin …

Exposure to asbestos is a risk for malignant mesothelioma (MM) in humans. Among the
commercially used types of asbestos (chrysotile, crocidolite, and amosite), the …

Introduction There is increasing interest in identifying a blood-based marker for the asbestos-
related tumor, malignant mesothelioma. Three potential markers for mesothelioma are …

Rationale: Soluble mesothelin (SM) is currently the reference serum biomarker of malignant
pleural mesothelioma (MPM). Megakaryocyte potentiating factor (MPF), which originates …

The sensitive simultaneous detection of multiple biomarkers is critical for the early diagnosis
of diseases. Electrochemiluminescence (ECL) offers outstanding advantages, eg, low …

Background Evaluate and compare the utility of serum folate receptor alpha (FRA) and
megakaryocyte potentiating factor (MPF) determinations relative to serum CA125 …

Introduction and Methods We investigated the diagnostic and prognostic value of soluble
mesothelin-related proteins (SMRP) in sera from patients with newly diagnosed malignant …

Liver cancer is one of the most common malignancies worldwide. Hepatocellular carcinoma
(HCC) and cholangiocarcinoma (CCA) are the two most common primary liver cancers, yet …